| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1130-6343(08)72823-X |
| P698 | PubMed publication ID | 18783711 |
| P2093 | author name string | Alfonso Domínguez | |
| María Victoria | |||
| Pedro Olaechea | |||
| Santiago Grau | |||
| Dolors Soy | |||
| Francisco Alvarez | |||
| Mónica Marín | |||
| Sociedad Española de Farmacología Clínica | |||
| Belén Sádaba | |||
| Africa Mediavilla | |||
| Daniel Fatela | |||
| Grupo de Estudio de Infección en el paciente crítico (GEIPC-SEIMC) | |||
| José Martínez-Lanao | |||
| Manuel Alos | |||
| Sociedad Andaluza de Análisis Clínicos (SANAC) | |||
| Sociedad Española de Farmacia Hospitalaria | |||
| P2860 | cites work | Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia | Q22241905 |
| Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy | Q24519008 | ||
| Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored? | Q33545113 | ||
| Some international approaches to aminoglycoside monitoring in the extended dosing interval era. | Q33708718 | ||
| Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit | Q33979524 | ||
| Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions | Q34458355 | ||
| Extended interval aminoglycoside dosing: from concept to clinic | Q34615905 | ||
| Pharmacological principles of antibiotic prescription in the critically ill. | Q34632743 | ||
| Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock | Q34983258 | ||
| Liquid chromatography-tandem mass spectrometry--application in the clinical laboratory | Q35095109 | ||
| The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration | Q35873510 | ||
| Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability | Q36263480 | ||
| The pharmacokinetic and pharmacodynamic properties of vancomycin | Q36328971 | ||
| The role of vancomycin in the treatment paradigm | Q36328981 | ||
| Pharmacokinetic changes in critical illness | Q36469758 | ||
| Evaluation of vancomycin for therapy of adult pneumococcal meningitis | Q36757364 | ||
| Words without action? The production, dissemination, and impact of consensus recommendations | Q37758750 | ||
| Experience with a once-daily aminoglycoside program administered to 2,184 adult patients | Q39779327 | ||
| Penetration of vancomycin into mediastinal and cardiac tissues in humans | Q40285124 | ||
| Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis | Q40988370 | ||
| Pharmacokinetics of drugs used in critically ill adults | Q41706103 | ||
| Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials | Q42671287 | ||
| Experience with a once-daily dosing program of aminoglycosides in critically ill patients | Q44067363 | ||
| Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire | Q44198696 | ||
| Penetration of vancomycin into human lung tissue | Q44470518 | ||
| A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes | Q44473953 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion | Q44991015 | ||
| Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections | Q45127594 | ||
| Monitoring plasma antibiotic concentrations in Spanish hospitals | Q46990279 | ||
| Pharmacokinetics of antibiotics in critically ill patients. | Q51742431 | ||
| “Homogeneous” enzyme immunoassay. A new immunochemical technique | Q70457875 | ||
| Aminoglycoside volume of distribution and illness severity in critically ill septic patients | Q70776962 | ||
| Stability of therapeutic drug measurement in specimens collected in VACUTAINER plastic blood-collection tubes | Q71342439 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 113-123 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria | Q26842251 |
| P1476 | title | Recommendations for antibiotic monitoring in ICU patients | |
| P478 | volume | 32 |
Search more.